论文部分内容阅读
目的评价门静脉持续灌注化疗联合肝动脉化疗栓塞治疗原发性肝癌的疗效。方法 90例原发性肝癌患者,分成观察组和对照组。对照组采用肝动脉化疗栓塞治疗;观察组采用门静脉持续灌注化疗联合肝动脉化疗栓塞治疗。结果观察组总有效率为55.56%优于对照组总有效率31.11%,差异有统计学意义(P<0.05)。结论门静脉持续灌注化疗联合肝动脉化疗栓塞治疗原发性肝癌疗效可靠。
Objective To evaluate the efficacy of continuous perfusion chemotherapy of portal vein combined with transcatheter arterial chemoembolization in the treatment of primary liver cancer. Methods 90 patients with primary liver cancer were divided into observation group and control group. The control group was treated with transcatheter arterial chemoembolization. The observation group was treated with continuous portal vein chemotherapy combined with transcatheter arterial chemoembolization. Results The total effective rate in the observation group was 55.56%, which was significantly higher than that in the control group (31.11%). The difference was statistically significant (P <0.05). Conclusion Continuous portal vein chemotherapy combined with transcatheter arterial chemoembolization in the treatment of primary liver cancer is reliable.